H

Hansoh Pharmaceutical Group Company Ltd
HKEX:3692

Watchlist Manager
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Watchlist
Price: 17.82 HKD -0.67%
Market Cap: 105.8B HKD
Have any thoughts about
Hansoh Pharmaceutical Group Company Ltd?
Write Note

Intrinsic Value

The intrinsic value of one Hansoh Pharmaceutical Group Company Ltd stock under the Base Case scenario is 16.34 HKD. Compared to the current market price of 17.82 HKD, Hansoh Pharmaceutical Group Company Ltd is Overvalued by 8%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

Intrinsic Value
16.34 HKD
Overvaluation 8%
Intrinsic Value
Price
H
Worst Case
Base Case
Best Case

Valuation History
Hansoh Pharmaceutical Group Company Ltd

Intrinsic Value History
Dive into the past to invest in the future

Uncover deeper insights with the Valuation History. Learn how current stock valuations stack up against historical averages to gauge true investment potential.

Start now and learn if your stock is truly undervalued or overvalued!

Start Valuation
Backtest Conclusion
Very Attractive
Current Valuation
+45%
Avg Valuation
-12%
Worst Valuation
-49%
Best Valuation
+45%

Stock is trading at its lowest valuation over the past 5 years.

Backtest Example
Register to View Results
Register to View Results

To access the results of this valuation backtest, please register an account with us. Registration is quick and gives you instant access to insights on 3 stocks per week for free.

Valuation History Unavailable

Historical valuation for Hansoh Pharmaceutical Group Company Ltd cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
How do you feel about Hansoh Pharmaceutical Group Company Ltd?
Bearish
Neutral
Bullish

Fundamental Analysis

17.82 HKD
-0.67%
-0.67%
Benchmark
Company Quality
No Indicators Selected
Select Indicators

Select up to 3 indicators:

Insider Trading
0-3
Months
0-6
Months
0-12
Months
0-36
Months
No Periods Selected
Select Periods

Select up to 2 periods:

Hansoh Pharmaceutical Group Company Ltd
CN
Pharmaceuticals
Market Cap
105.7B HKD
IPO
Jun 14, 2019
Employees
12 030
China
Market Cap
105.7B HKD
Industry
Pharmaceuticals
IPO
Jun 14, 2019
Company Overview
Loading...
Business Segments
Loading...
Economic Moat
Loading...
Management
Loading...
Contacts
Loading...
AI Assistant
AI Assistant
Ask me anything about Hansoh Pharmaceutical Group Company Ltd

Provide an overview of the primary business activities
of Hansoh Pharmaceutical Group Company Ltd.

What unique competitive advantages
does Hansoh Pharmaceutical Group Company Ltd hold over its rivals?

What risks and challenges
does Hansoh Pharmaceutical Group Company Ltd face in the near future?

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Hansoh Pharmaceutical Group Company Ltd.

Provide P/S
for Hansoh Pharmaceutical Group Company Ltd.

Provide P/E
for Hansoh Pharmaceutical Group Company Ltd.

Provide P/OCF
for Hansoh Pharmaceutical Group Company Ltd.

Provide P/FCFE
for Hansoh Pharmaceutical Group Company Ltd.

Provide P/B
for Hansoh Pharmaceutical Group Company Ltd.

Provide EV/S
for Hansoh Pharmaceutical Group Company Ltd.

Provide EV/GP
for Hansoh Pharmaceutical Group Company Ltd.

Provide EV/EBITDA
for Hansoh Pharmaceutical Group Company Ltd.

Provide EV/EBIT
for Hansoh Pharmaceutical Group Company Ltd.

Provide EV/OCF
for Hansoh Pharmaceutical Group Company Ltd.

Provide EV/FCFF
for Hansoh Pharmaceutical Group Company Ltd.

Provide EV/IC
for Hansoh Pharmaceutical Group Company Ltd.

Show me price targets
for Hansoh Pharmaceutical Group Company Ltd made by professional analysts.

What are the Revenue projections
for Hansoh Pharmaceutical Group Company Ltd?

How accurate were the past Revenue estimates
for Hansoh Pharmaceutical Group Company Ltd?

What are the Net Income projections
for Hansoh Pharmaceutical Group Company Ltd?

How accurate were the past Net Income estimates
for Hansoh Pharmaceutical Group Company Ltd?

What are the EPS projections
for Hansoh Pharmaceutical Group Company Ltd?

How accurate were the past EPS estimates
for Hansoh Pharmaceutical Group Company Ltd?

What are the EBIT projections
for Hansoh Pharmaceutical Group Company Ltd?

How accurate were the past EBIT estimates
for Hansoh Pharmaceutical Group Company Ltd?

Compare the revenue forecasts
for Hansoh Pharmaceutical Group Company Ltd with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Hansoh Pharmaceutical Group Company Ltd and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Hansoh Pharmaceutical Group Company Ltd against its competitors.

Analyze the profit margins
(gross, operating, and net) of Hansoh Pharmaceutical Group Company Ltd compared to its peers.

Compare the P/E ratios
of Hansoh Pharmaceutical Group Company Ltd against its peers.

Discuss the investment returns and shareholder value creation
comparing Hansoh Pharmaceutical Group Company Ltd with its peers.

Analyze the financial leverage
of Hansoh Pharmaceutical Group Company Ltd compared to its main competitors.

Show all profitability ratios
for Hansoh Pharmaceutical Group Company Ltd.

Provide ROE
for Hansoh Pharmaceutical Group Company Ltd.

Provide ROA
for Hansoh Pharmaceutical Group Company Ltd.

Provide ROIC
for Hansoh Pharmaceutical Group Company Ltd.

Provide ROCE
for Hansoh Pharmaceutical Group Company Ltd.

Provide Gross Margin
for Hansoh Pharmaceutical Group Company Ltd.

Provide Operating Margin
for Hansoh Pharmaceutical Group Company Ltd.

Provide Net Margin
for Hansoh Pharmaceutical Group Company Ltd.

Provide FCF Margin
for Hansoh Pharmaceutical Group Company Ltd.

Show all solvency ratios
for Hansoh Pharmaceutical Group Company Ltd.

Provide D/E Ratio
for Hansoh Pharmaceutical Group Company Ltd.

Provide D/A Ratio
for Hansoh Pharmaceutical Group Company Ltd.

Provide Interest Coverage Ratio
for Hansoh Pharmaceutical Group Company Ltd.

Provide Altman Z-Score Ratio
for Hansoh Pharmaceutical Group Company Ltd.

Provide Quick Ratio
for Hansoh Pharmaceutical Group Company Ltd.

Provide Current Ratio
for Hansoh Pharmaceutical Group Company Ltd.

Provide Cash Ratio
for Hansoh Pharmaceutical Group Company Ltd.

What is the historical Revenue growth
over the last 5 years for Hansoh Pharmaceutical Group Company Ltd?

What is the historical Net Income growth
over the last 5 years for Hansoh Pharmaceutical Group Company Ltd?

What is the current Free Cash Flow
of Hansoh Pharmaceutical Group Company Ltd?

Discuss the annual earnings per share (EPS)
trend over the past five years for Hansoh Pharmaceutical Group Company Ltd.

Financials
Annual
Quarterly
TTM
Annual
Quarterly
TTM

Revenue & Expenses Breakdown
Hansoh Pharmaceutical Group Company Ltd

Balance Sheet Decomposition
Hansoh Pharmaceutical Group Company Ltd

Current Assets 27.4B
Cash & Short-Term Investments 23.5B
Receivables 2.9B
Other Current Assets 970.4m
Non-Current Assets 4.3B
Long-Term Investments 743.4m
PP&E 3.3B
Intangibles 196.6m
Current Liabilities 3.4B
Accounts Payable 174.6m
Accrued Liabilities 2.1B
Other Current Liabilities 1.2B
Non-Current Liabilities 336.6m
Long-Term Debt 64.1m
Other Non-Current Liabilities 272.5m
Efficiency

Earnings Waterfall
Hansoh Pharmaceutical Group Company Ltd

Revenue
12.1B CNY
Cost of Revenue
-1.1B CNY
Gross Profit
11B CNY
Operating Expenses
-6.8B CNY
Operating Income
4.2B CNY
Other Expenses
500.8m CNY
Net Income
4.7B CNY

Free Cash Flow Analysis
Hansoh Pharmaceutical Group Company Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate
Fundamental Scores

Profitability Score
Profitability Due Diligence

Hansoh Pharmaceutical Group Company Ltd's profitability score is 73/100. The higher the profitability score, the more profitable the company is.

Exceptional 3-Year Average ROIC
Positive Gross Profit
Positive Free Cash Flow
Exceptional ROIC
73/100
Profitability
Score

Hansoh Pharmaceutical Group Company Ltd's profitability score is 73/100. The higher the profitability score, the more profitable the company is.

Solvency Score
Solvency Due Diligence

Hansoh Pharmaceutical Group Company Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

Hansoh Pharmaceutical Group Company Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

Price Targets Summary
Hansoh Pharmaceutical Group Company Ltd

Wall Street analysts forecast Hansoh Pharmaceutical Group Company Ltd stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for Hansoh Pharmaceutical Group Company Ltd is 23.98 HKD with a low forecast of 18.13 HKD and a high forecast of 31.5 HKD.

Lowest
Price Target
18.13 HKD
2% Upside
Average
Price Target
23.98 HKD
35% Upside
Highest
Price Target
31.5 HKD
77% Upside
View Analyst Estimates
View Analyst Estimates
Want to learn more about Wall St estimates for Hansoh Pharmaceutical Group Company Ltd?

Click here to dive deeper.

Dividends

Dividend Yield
Lowest
Average
Highest
Dividend Per Share
N/A
Growth 3Y
Growth 5Y
Growth 10Y
Dividend Safety Score
Very
Unsafe
Unsafe
Safe
Very
Safe
0
25
50
75
100
Shareholder Yield

Current shareholder yield for Hansoh Pharmaceutical Group Company Ltd is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
Lowest
Average
Highest
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

See Also

Discover More
What is the Intrinsic Value of one Hansoh Pharmaceutical Group Company Ltd stock?

The intrinsic value of one Hansoh Pharmaceutical Group Company Ltd stock under the Base Case scenario is 16.34 HKD.

Is Hansoh Pharmaceutical Group Company Ltd stock undervalued or overvalued?

Compared to the current market price of 17.82 HKD, Hansoh Pharmaceutical Group Company Ltd is Overvalued by 8%.

Back to Top